Product Information
TAMSULOSIN HCL 0.4 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $0.0525 per EA under NDC 00781207601. Its NADAC has been published 599 times since Nov 28, 2013.
FDA first approved this application on Apr 27, 2010.
The High Outlier badge above means this manufacturer's average price in the tamsulosin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.4 mg/1
Manufacturer
Sandoz Inc.NDC
00781207601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
TAMSULOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078015FDA Approved
4/27/2010
On Market Since
4/27/2010
Pharmacological Classes
Price Statistics
The NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has been published 599 times since Nov 28, 2013, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0525 per EA |
|---|---|
| All-time high | $0.5414 (Dec 10, 2014) |
| All-time low | $0.0435 (Nov 20, 2024) |
| Median price | $0.0841 |
| Average price | $0.1312 |
| Largest weekly change | +131.0% (Nov 12, 2014) |
| Weeks tracked | 599 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-10.6%
5Y
-18.9%
All
-61.7%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tamsulosin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tamsulosin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAMSULOSIN HCL 0.4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMSULOSIN HCL 0.4 MG CAPSULE, manufactured by Sandoz Inc., is $0.0525 per EA (NDC 00781207601), effective May 14, 2025.
How has the price of TAMSULOSIN HCL 0.4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has declined 61.7%. It has been tracked across 599 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMSULOSIN HCL 0.4 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has ranged from a low of $0.0435 (Nov 20, 2024) to a high of $0.5414 (Dec 10, 2014), with a median of $0.0841 per EA.
Are there cheaper alternatives to TAMSULOSIN HCL 0.4 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TAMSULOSIN HCL 0.4 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TAMSULOSIN HCL 0.4 MG CAPSULE?
TAMSULOSIN HCL 0.4 MG CAPSULE (NDC 00781207601) is labeled by Sandoz Inc., and CMS classifies it as a generic product.